Welcome to our dedicated page for Methanex news (Ticker: MEOH), a resource for investors and traders seeking the latest updates and insights on Methanex stock.
Methanex Corporation reports developments tied to its global methanol production, marketing and distribution business. The company supplies methanol to customers in Asia Pacific, North America, Europe and South America, with production sites in Canada, Chile, Egypt, New Zealand, Trinidad and Tobago, and the United States.
Recurring news covers methanol production volumes, realized pricing, quarterly and annual operating results, cash dividends, balance-sheet actions, shareholder meeting results, board governance and sustainability reporting. Company updates also include low-carbon methanol market development and biomethanol fuel-supply initiatives for marine and industrial uses.
Methanex (NASDAQ:MEOH), the largest global supplier of methanol, has pledged NZ$2 million to construct a new neonatal unit at Taranaki Base Hospital, New Zealand. This investment is part of a 10-year initiative aimed at improving care for vulnerable newborns and their families, with the new unit expected to be ready by 2025. Alongside government funding for essential services, the Taranaki Health Foundation aims to raise NZ$25 million for further enhancements to critical hospital services, highlighting Methanex's commitment to the local community and economic support.
Summary not available.
Methanex Corporation (NASDAQ: MEOH) has declared a quarterly dividend of US$0.175 per share, payable on December 31, 2022. Shareholders of record as of December 17, 2022 will receive this dividend. Methanex, based in Vancouver, is the world's largest producer of methanol, serving major international markets. The company trades under the ticker symbol MEOH on NASDAQ and MX on the TSX.
Methanex reported net income of $69 million for Q3 2022, down from $125 million in Q2 2022, mainly due to lower methanol prices and planned turnarounds in Egypt and New Zealand. Adjusted EBITDA was $192 million, also lower than the previous quarter's $243 million. The company is on track to start producing methanol from the Geismar 3 project in Q4 2023, funded with cash on hand. In July, they increased the quarterly dividend by 20% and announced a 5% share repurchase program. Methanex ended Q3 with $962 million in cash, maintaining robust liquidity.
Summary not available.
Methanex Corporation (NASDAQ: MEOH) announced a multi-million-dollar investment to enhance carbon emissions reduction at its Motunui facility in New Zealand. The upgrade to distillation technology will be implemented over the next 12 months, with an anticipated economic payback in two years. Upon completion, the project could reduce carbon emissions by over 50,000 tonnes annually, equivalent to removing 20,000 cars from the road. This initiative aligns with Methanex's commitment to sustainability and the transition to a low-carbon economy.
Methanex Corporation (NASDAQ: MEOH) announced that the Toronto Stock Exchange approved its Normal Course Issuer Bid (NCIB) to buy back up to 3,506,405 shares, equating to 5% of its outstanding shares. The buyback will commence on September 26, 2022, and conclude by September 25, 2023, with daily limits on purchases. This decision reflects Methanex's strong financial position and commitment to returning excess cash to shareholders, following a previous buyback from September 2021 to July 2022 that successfully canceled over 6 million shares.
Methanex Corporation (NASDAQ: MEOH) announced a leadership change, with John Floren retiring as President and CEO on December 31, 2022. Rich Sumner, currently Senior Vice President of Global Marketing & Logistics, will succeed him starting January 1, 2023. The Board of Directors expressed confidence in Sumner's ability to lead the company, emphasizing his extensive experience since 2004. Under Floren, Methanex enhanced its production and returned approximately $2 billion to shareholders. The transition is aimed at reinforcing Methanex’s leading position in the methanol industry and fostering long-term shareholder value.
Methanex Corporation announced the approval of a Normal Course Issuer Bid (NCIB) to purchase up to 3,506,405 common shares, equating to 5% of its outstanding shares as of September 15, 2022. Purchases will commence no earlier than September 26, 2022, on the Toronto Stock Exchange (TSX). The NCIB aims to enhance shareholder value and reflects the company's strong balance sheet. Previously, Methanex repurchased 3,810,464 shares under a prior NCIB at an average price of $47.83.
Methanex reported a net income of $125 million for Q2 2022, with an Adjusted EBITDA of $243 million. The Geismar 3 project’s capital cost has been reduced by $50 million to $1.3 billion, with production expected by Q4 2023. The board announced a 20% dividend increase to $0.175 per share, reflecting a commitment to shareholder returns. Despite lower methanol sales and rising costs, cash reserves are strong at $878 million. Production decreased to 1,551,000 tonnes compared to the previous quarter, influenced by gas availability constraints in New Zealand.